Botanix Pharmaceuticals Limited (ASX:BOT)
Australia · Delayed Price · Currency is AUD 0.0200
+0.0010 (5.26%)
Sep 11, 2026, 11:24 AM AEST
Botanix Pharmaceuticals Market Cap
Botanix Pharmaceuticals has a market cap or net worth of 52 million as of September 10, 2026. Its market cap has decreased by -80.36% in one year.
Market Cap
52.00M
Enterprise Value
16.28M
Revenue
33.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since July 15, 2016, Botanix Pharmaceuticals's market cap has increased from 12.26M to 52.00M, an increase of 323.95%. That is a compound annual growth rate of 15.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 52.00M | -80.43% |
| Dec 31, 2025 | 265.72M | -66.39% |
| Dec 31, 2024 | 790.67M | 168.97% |
| Dec 29, 2023 | 293.96M | 367.07% |
| Dec 30, 2022 | 62.94M | 15.49% |
| Dec 31, 2021 | 54.50M | -55.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 84.53M |
| Avecho Biotechnology | 81.14M |
| Arovella Therapeutics | 73.74M |
| Prescient Therapeutics | 68.35M |
| Entropy Neurodynamics | 66.94M |
| Neurizon Therapeutics | 65.88M |
| Immutep | 64.84M |
| Amplia Therapeutics | 61.60M |